Severe Anemia: A Hidden Threat in CKD, Nephrology, Nephrologist, Cresp, Anemia, CKD
This article is brought to you by Cresp
Abbreviations ▼
CKD: Chronic kidney disease; CV: Cardiovascular; Hb: Haemoglobin; HR-QoL: Health-related quality of life; RR: Relative risk.
References ▼
1. The DOPPS Practice Monitor. Anemia. US-DOPPS. 2016. 2. Locatelli F, Pisoni RL, Combe C, et al. Anaemia in haemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation. 2004;19(1):121–132. 3. Covic A, Jackson J, Hadfield A, et al. Real-World impact of cardiovascular disease and anemia on quality of life and productivity in patients with non-dialysis-dependent chronic kidney disease. Adv Ther. 2017 34(7):1662–1672. 4. Locatelli F, Del Vecchio L. Are we approaching a new era in the treatment of anemia of chronic kidney disease patients? Ann Transl Med. 2019;7(Suppl 8):S333. 5. Hanna RM, Streja E, Kalantar-Zadeh K. Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin. Adv Ther. 2021;38:52–75. 6. Gouva C, Nikolopoulos P, Ioannidis JP, et al. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 2004;66(2):753–760.
LMRC Code: GGI-CO-A1-AQS-300027678-BANNERS-G24-0738
